TABLE 2.
Analysis of LY% in ADC patients
| LY% | No. (%) |
Total (n = 675) |
p value |
|
|---|---|---|---|---|
|
20–50 (n = 392) |
<20 (n = 283) |
|||
| Basic characteristics | ||||
| Age | 0.639 | |||
| <45 | 38(9.7) | 29(10.2) | 67 | |
| 45–60 | 168(42.9) | 111(39.2) | 279 | |
|
>60 |
186(47.4) | 143(50.5) | 329 | |
| Sex | 0.006** | |||
| Male | 192(49.0) | 169(59.7) | 361 | |
| Female | 200(51.0) | 114(40.3) | 314 | |
| Stage | 0.000*** | |||
| I | 57(14.5) | 10(3.6) | 67 | |
| II | 38(9.8) | 13(4.6) | 51 | |
| III | 68(17.3) | 55(19.4) | 123 | |
| IV | 210(53.6) | 190(67.1) | 400 | |
| Unknown | 19(4.8) | 15(5.3) | 34 | |
| Smoking status | 0.434 | |||
| Never smoking | 243(62.0) | 167(59.0) | 410 | |
| Current or ex‐smoker |
149(38.0) |
116(41.0) |
265 |
|
| Differentiation | 0.000*** | |||
| Undifferentiated | 235(59.9) | 210(74.2) | 445 | |
| Poor | 33(8.4) | 41(14.5) | 74 | |
| Moderate | 118(30.2) | 28(9.8) | 146 | |
| Well | 4(1.0) | 1(0.4) | 5 | |
| Unknown | 2(0.5) | 3(1.1) | 5 | |
| Metastasis | ||||
| Brain | 0.135 | |||
| No | 349(89.0) | 241(85.2) | 590 | |
| Yes | 43(11.0) | 42(14.8) | 85 | |
| Bone | 0.000*** | |||
| No | 321(81.9) | 198(70.0) | 519 | |
| Yes | 71(18.1) | 85(30.0) | 156 | |
| Liver | 0.007** | |||
| No | 371(94.6) | 252(89.0) | 623 | |
| Yes | 21(5.4) | 31(11.0) | 52 | |
| Adrenal gland | 0.008** | |||
| No | 382(97.4) | 264(93.3) | 646 | |
| Yes | 10(2.6) | 19(6.7) | 29 | |
| Lymph node | 0.025* | |||
| No | 192(49.0) | 114(40.3) | 306 | |
| Yes | 200(51.0) | 169(59.7) | 369 | |
| Intrapulmonary | 0.959 | |||
| No | 343(87.5) | 248(87.6) | 591 | |
| Yes | 49(12.5) | 35(12.4) | 84 | |
| Pleural | 0.000*** | |||
| No | 340(86.7) | 216(76.3) | 556 | |
| Yes | 52(13.3) | 67(23.7) | 119 | |
| Mediastinal | 0.045* | |||
| No | 387(98.7) | 273(96.5) | 660 | |
| Yes | 5(1.3) | 10(3.5) | 15 | |
*
p < 0.05, **p < 0.01, ***p < 0.001. LY%: lymphocyte percentage; ADC: lung adenocarcinoma; poor: poorly differentiated; moderate: moderately differentiated; well: well differentiated.